Alemtuzumab induction therapy in HIV-positive renal transplant recipients.

Florence E Mclean Esther Gathogo Dawn Goodall Rachael Jones Sabine Kinloch Frank A Post

AIDS

aDepartment of Renal Medicine, St George's Hospital bDepartment of Renal Sciences, King's College London cImperial College Kidney and Transplant Centre, Hammersmith Hospital dDepartment of HIV Medicine, Chelsea and Westminster Hospital eDivision of Infection and Immunity, University College London fDepartment of HIV Research, King's College Hospital NHS Foundation Trust, London, UK.

Published: April 2017

Download full-text PDF	Source
http://dx.doi.org/10.1097/QAD.0000000000001413	DOI Listing

Publication Analysis

Top Keywords

alemtuzumab induction

induction therapy

therapy hiv-positive

hiv-positive renal

renal transplant

transplant recipients

alemtuzumab

therapy

hiv-positive

renal

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!